Combined positive score using 28–8 predicts nivolumab efficacy in HNSCC

Oral Oncology 2026

View at publisher
Authors: Ryosuke Sato, Takahiro Inoue, Shota Sakaue, Hisataka Ominato, Risa Wakisaka, Hiroki Komatsuda, Michihisa Kono, Hidekiyo Yamaki, Kenzo Ohara, Takumi Kumai, Kan Kishibe, Mishie Ann Tanino
+1 more Miki Takahara
DOI: 10.1016/j.oraloncology.2026.107954
Cited by: 1
References: 9

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers CAR-T cell therapy research Inflammatory Biomarkers in Disease Prognosis

Publication details

Journal / source
Oral Oncology
Publisher
Elsevier BV
Volume
176
Pages
107954–107954
Publication date
28 March 2026
Language
EN